Clinical Trial Feasibility and Capacity Planning Tool

June 23rd, 2020|

1. GENERAL INFORMATION Full Study Title and Trial Number: Sponsor: PI Undertaking Study: Intended Study Commencement Date: HREC Submission Date: Date of Site Selection: Assigned Lead CTC: Start Up Primary Contact Sponsor/CRO: Name: Email: [...]

Medical Writing – What Does a Medical Writer Do?

March 2nd, 2020|

Medical writing is a profession dedicated to the communication of medical, scientific and health information, including research reports, consumer (patient) information, and regulatory documents. What is a Medical Writer? A professional medical writer is [...]

GRS Newsletter – February 2020

February 3rd, 2020|

Welcome to the new year with Genesis. First of all, our thoughts go out to those affected by the bushfires here in Australia. Our deepest gratitude goes out to the incredible people fighting the [...]

GRS Newsletter – September 2019

September 26th, 2019|

This year has been exceptionally busy for Genesis! We waved goodbye to our longest serving team member and welcomed new staff and investigators. We celebrated significant study enrolment milestones and the initiation of our [...]

Did You Know that Genesis Conducts its Own Studies?

June 3rd, 2019|

Most clinical trials are developed, funded and managed by pharmaceutical or medical device companies. Here at Genesis Research, we also conduct “investigator-initiated studies”. These are research studies that are developed and managed by our [...]

Genesis Workplace Health and Safety

February 18th, 2019|

Over the past 4 years GRS has created and implemented a unique and standardised framework for workplace health and safety in clinical trials research at a site level. This robust system represents our strong [...]

Migraine – Symptoms, Treatment & Clinical Trials

February 14th, 2019|

Migraine is a neurological disorder that is typically defined as recurring attacks of moderate to severe headaches and accompanying symptoms (particularly neurological and sensory symptoms). Migraine may be a primary condition, or it may [...]

Did You Know That Genesis Funds Its Own Research?

November 9th, 2018|

So far in 2018 we have invested over $30,000 of our own funds into research to further our understanding of what causes Complex Regional Pain Syndrome. This novel internal investigation has enabled new collaborations [...]

Precautious measures against COVID-19

To reduce the spread of COVID 19, we will be contacting participants before their appointments to ensure they are well. In order to protect both participants and staff, we have implemented daily temperature checking for all. This continuous monitoring is the only way to reduce the incidence of infection. We trust you understand that we have your best interests at heart and hope you stay well.

Get the latest updates about COVID-19

Go to Top